Literature DB >> 17031520

Epidemiological and virological features of HBV infection in HIV-2 infected patients living in southeastern France.

Philippe Colson1, Mireille Henry, Anne Motte, Hervé Gallais, Jacques Moreau, Isabelle Poizot-Martin, Catherine Tamalet.   

Abstract

We studied HBV infection in 34 HIV-2-infected patients followed-up in Marseilles. Ten (29%) patients were chronically-infected with HBV, which represents a three-times higher rate than in HIV-1-infected patients in Europe. HBV occult infection was diagnosed in two patients. HBV genotype E was found in seven patients; its specificities and the reciprocal influence of HIV-2/HBV-co-infection remain to be evaluated.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17031520     DOI： 10.1007/s10654-006-9039-4

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


  11 in total

Review 1.  Clinical relevance of hepatitis B viral mutations.

Authors:  C M Hunt; J M McGill; M I Allen; L D Condreay
Journal:  Hepatology       Date:  2000-05       Impact factor: 17.425

Review 2.  Human immunodeficiency virus type 2.

Authors:  Jacqueline D Reeves; Robert W Doms
Journal:  J Gen Virol       Date:  2002-06       Impact factor: 3.891

3.  Fulminant hepatitis B associated with a specific insertion in the basal core promoter region of hepatitis B virus DNA after immunosuppressive treatment.

Authors:  René Gérolami; Mireille Henry; Patrick Borentain; Philippe Colson; Danièle Botta; Catherine Tamalet
Journal:  Clin Infect Dis       Date:  2005-01-21       Impact factor: 9.079

4.  Analysis of HBs antigen negative variant of hepatitis B virus: unique substitutions, Glu129 to Asp and Gly145 to Ala in the surface antigen gene.

Authors:  T Koyanagi; M Nakamuta; H Sakai; R Sugimoto; M Enjoji; K Koto; H Iwamoto; T Kumazawa; M Mukaide; H Nawata
Journal:  Med Sci Monit       Date:  2000 Nov-Dec

5.  Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation.

Authors:  U Protzer-Knolle; U Naumann; R Bartenschlager; T Berg; U Hopf; K H Meyer zum Büschenfelde; P Neuhaus; G Gerken
Journal:  Hepatology       Date:  1998-01       Impact factor: 17.425

6.  Polymorphism and drug-selected mutations in the reverse transcriptase gene of HIV-2 from patients living in southeastern France.

Authors:  Philippe Colson; Mireille Henry; Natacha Tivoli; Hervé Gallais; Jean-Albert Gastaut; Jacques Moreau; Catherine Tamalet
Journal:  J Med Virol       Date:  2005-03       Impact factor: 2.327

7.  Factors associated with clinical progression in HIV-2 infected-patients: the French ANRS cohort.

Authors:  Sophie Matheron; Sophie Pueyo; Florence Damond; François Simon; Annie Leprêtre; Pauline Campa; Roger Salamon; Genevieve Chêne; Françoise Brun-Vezinet
Journal:  AIDS       Date:  2003-12-05       Impact factor: 4.177

8.  HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study.

Authors:  François Rouet; Marie-Laure Chaix; André Inwoley; Philippe Msellati; Ida Viho; Patrice Combe; Valériane Leroy; François Dabis; Christine Rouzioux
Journal:  J Med Virol       Date:  2004-09       Impact factor: 2.327

9.  The prevalence of hepatitis B surface antigenaemia in HIV positive patients in the Niger Delta Nigeria.

Authors:  O A Ejele; C A Nwauche; O Erhabor
Journal:  Niger J Med       Date:  2004 Apr-Jun

10.  Low genetic diversity despite hyperendemicity of hepatitis B virus genotype E throughout West Africa.

Authors:  Mick N Mulders; Veronique Venard; Mounjohou Njayou; A Patrick Edorh; Akeeb O Bola Oyefolu; M O Kehinde; Jean-Jacques Muyembe Tamfum; Yacouba K Nebie; Ibrahim Maiga; Wim Ammerlaan; Fred Fack; Sunday A Omilabu; Alain Le Faou; Claude P Muller
Journal:  J Infect Dis       Date:  2004-06-22       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.